Prelude Capital Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Prelude Capital Management’s Portfolio FDMT Stock Details FDMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$76.8K	Sell
2025 Q1	$72.7K	Buy
2023 Q1	–	Sell
2022 Q4	$281K	Buy